E
Energenesis Biomedical Co Ltd
TWSE:6657
Energenesis Biomedical Co Ltd
TWSE:6657
Price:
44.35
TWD
-2.85%
Market Closed
Market Cap:
NT$3.9B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
TW |
|
A
|
Airship AI Holdings Inc
NASDAQ:AISP
|
US |
|
Taiwan Pelican Express Co Ltd
TWSE:2642
|
TW |
Relative Value
The Relative Value of one Energenesis Biomedical Co Ltd stock under the Base Case scenario is 5.12 TWD. Compared to the current market price of 44.35 TWD, Energenesis Biomedical Co Ltd is Overvalued by 88%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Relative Value
Base Case
5.12
TWD
Overvaluation 88%
E
Multiples Across Competitors
Competitors Multiples
Energenesis Biomedical Co Ltd Competitors
Energenesis Biomedical Co Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TW |
E
|
Energenesis Biomedical Co Ltd
TWSE:6657
|
3.9B TWD | 527.4 | -16.1 | -13.1 | -12 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
362.3B USD | 5.9 | 86.4 | 14.4 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188.5B USD | 5.1 | 24.4 | 14.2 | 14.2 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
170.4B USD | 5.8 | 20 | 12.5 | 15.4 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
114.6B USD | 9.5 | 28.9 | 21.7 | 22.7 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
77.9B USD | 5.4 | 17.2 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
67.4B AUD | 3.1 | 34.2 | 11.3 | 14.2 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 | |
| NL |
|
argenx SE
XBRU:ARGX
|
36B EUR | 10.1 | 32.5 | 35 | 35.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
